Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Company Overview More
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
CEO: Hershberg M.D., Ph.D., Robert M.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Futubull > Quotes > HLVX HilleVax > Detailed Quotes

HLVX HilleVax

Watchlist
9.910+0.240+2.48%
Close 05/26 20:00 ET
9.91000.00%
Pre Mkt Price 05/27 08:17 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
10.600
Open
10.420
Turnover
1.49M
Low
9.750
Pre Close
9.670
Volume
147.73K
Market Cap
299.20M
P/E(TTM)
Loss
52wk High
20.950
Shares
30.19M
P/E(Static)
Loss
52wk Low
8.820
Float Cap
102.01M
Bid/Ask %
-12.50%
Historical High
20.950
Shs Float
10.29M
Volume Ratio
0.73
Historical Low
8.820
Dividend TTM
--
Div Yield TTM
--
P/B
-2.97
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.44%
Amplitude
8.79%
Avg Price
10.109
Lot Size
1
Float Cap
102.01M
Bid/Ask %
-12.50%
Historical High
20.950
Shs Float
10.29M
Volume Ratio
0.73
Historical Low
8.820
Dividend TTM
--
P/B
-2.97
Dividend LFY
--
Turnover Ratio
1.44%
Amplitude
8.79%
Avg Price
10.109
Lot Size
1
Price Forecast

No Data

News

Comment

Back to the Top